IP Infusion's OcNOS® provides a feature-rich upgrade platform for French internet and managed service provider
SANTA CLARA, Calif., March 27, 2024 – IP Infusion, the market leader in carrier-grade networking software systems, announced today that Prosoluce, an internet and managed service provider based in France, has chosen to upgrade its backbone network with IP Infusion software and 100G open networking hardware from Edgecore Networks. Open networking systems integrator Pine Networks, which specializes in open, disaggregated, and virtualized solutions, guided Prosoluce through this journey of backbone upgrade.
Prosoluce is a regional internet service provider, cloud provider, and managed services provider. Responding to growing demand and addressing upgrade limitations with its 10G backbone network, Prosoluce 决定基于最先进的 EVPN-VXLAN 技术构建新的 IP 骨干网,以提供多站点与多租户服务。 After evaluating a competitive field of traditional vendor solutions and refurbished options, disaggregation with IP Infusion came as the best offering. Support from IP Infusion and Pine Networks was decisive in this evaluation process as Prosoluce refined its expectations.
Choosing an upgrade to its existing backbone posed specific interoperating challenges. The new solution required compatibility with Prosoluce's existing networking vendors, which at the time consisted of Alcatel Lucent, Huawei, MikroTik, and Ubiquiti equipment.
"Prosoluce's upgrade to open networking solved several problems at once," said Gaël Hermet, Directeur Général for Prosoluce. "Together with the benefits of a competitive technology and supported interoperability, we valued Pine Networks' recommendation for open networking to avoid single traditional vendor lock-in. IP Infusion software allowed for increased compatibility and performance while lowering costs."
"The benefits of open networking become clear as more organizations look into the Total Cost of Ownership of their network infrastructure," said Hadi Choueiry, General Manager for Pine Networks. "Perhaps more important than cost, open networking solutions provide our customers the flexibility and openness they need."
"With the support of partners and customers such as Pine Networks and Prosoluce, IP Infusion is working to be the open networking software vendor alternative to the networking industry," said Atsushi Ogata, President and CEO of IP Infusion. "Commercial application, an industry-leading price, and robust support are hallmarks of IP Infusion products."
关于 IP Infusion
IP Infusion manufactures open network software and solutions for carriers, service providers, and data centers. With hundreds of customers and thousands of deployments, IP Infusion is a market leader in Network Operating Systems. Our flagship software platform OcNOS® allows network operators to disaggregate their networks, streamline operations, and reduce Total Cost of Ownership (TCO). Network OEMs may also disaggregate network devices to expedite time to market, offer comprehensive services, and achieve carrier-grade robustness.
IP Infusion is headquartered in Santa Clara, Calif., and is a wholly owned and independently operated subsidiary of ACCESS CO., LTD. Additional information can be found at http://www.IPInfusion.com.
IP Infusion and OcNOS are trademarks or registered trademarks of IP Infusion. ACCESS is a registered trademark or trademark of ACCESS CO., LTD. in the United States, Japan and/or other countries. Northforge Innovations is a registered trademark of Northforge Innovations, Inc. All other trademarks, service marks, registered trademarks, or registered service marks mentioned are the property of their respective owners.
-end-
Media Contact:
Katherine Verducci
1903 PR
kverducci@1903pr.com
408.429.5779
关于 IP Infusion
IP Infusion 是开放网络软件的领先供应商，提供面向服务提供商、数据中心和 AI Fabric 网络的运营商级网络操作系统 OcNOS。凭借自 1999 年以来的网络技术积累和全球 600+ 家运营商的部署，IP Infusion 在 Edgecore Networks、UfiSpace 和 Celestica 等合作伙伴经过验证的开放硬件上，实现开放、多厂商、高性价比且灵活的网络基础设施。IP Infusion 是 ACCESS CO., LTD.（东京证券交易所：4813）的全资子公司。
媒体联系
For press inquiries, analyst briefings, or media materials, please 联系我们团队 or email pr@ipinfusion.com.
前瞻性陈述
本新闻稿可能包含有关 IP Infusion 产品、技术和计划的前瞻性陈述。前瞻性陈述基于发布之日可获得的信息，涉及风险和不确定性，实际结果可能存在差异。产品计划、功能、发布时间和供应情况可能随时变更，恕不另行通知，且不构成任何承诺、保证或法律义务。IP Infusion 不承担更新任何前瞻性陈述的义务。